INVESTOR RELATIONS

Investor Overview

Recent Newsmore >
DateTitle
05/15/17ViewRay Reports First Quarter 2017 Financial Results
Reiterates 2017 Financial Guidance CLEVELAND, May 15, 2017 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) today announced financial results for the first quarter ended March 31, 2017. First Quarter 2017 Highlights: Received new orders for MRIdian Linac Systems, totaling $12.3 million, compared to orders totaling $11.2 million in Q1 2016 Received orders totaling $5.8 million to upgrade installed MRIdian Cobalt Systems to Linac Systems Total backlog grew to $144.9 million, a... 
05/15/17Compelling Early Pancreatic Cancer Data with ViewRay's MRIdian System Presented at ESTRO 36
Presentations Also Highlighted Speed and Benefit of On-Table Adaptive Therapy in Routine Clinical Use CLEVELAND, May 15, 2017 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today highlights from ESTRO 36, the annual meeting of the European Society for Radiotherapy and Oncology, which featured broad clinical experience with the company's MRIdian System, including compelling early data on its use in pancreatic cancer. Pancreatic Cancer A presentation by Sasa Mutic, Ph.D., from Was... 
05/10/17ViewRay Announces Conference Call and Webcast of First Quarter 2017
Financial Results to be Held on May 15, 2017 CLEVELAND, May 10, 2017 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today details relating to the release of its first quarter 2017 financial results, which will take place on Monday, May 15, 2017 after market close. ViewRay will hold a conference call on Monday, May 15, 2017 at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results. The dial-in numbers are (844) 277-1426 for domestic callers and (336) 525-7129 for international callers. ... 
05/02/17ViewRay Showcases World's First Commercially Available MRI-Guided Linac System at Leading European Radiation Oncology Meeting
Clinical Presentations Highlight Benefits of MRI-Guidance for Pancreatic, Gastrointestinal, and Prostate Cancers Cancer Survivor Bibian Mentel, MRIdian Patient and Gold Medal Paralympian, Shares Her Story CLEVELAND, May 2, 2017 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that the company will showcase its next generation MRI-guided radiation therapy solution, MRIdian Linac, at ESTRO 36, the annual meeting of the European Society for Radiotherapy and Oncology, being held Ma... 
Corporate Profile

ViewRay® Inc., (NASDAQ:VRAY), designs, manufactures and markets MRIdian® the world’s first and only MRI-guided radiation therapy system that can image and treat cancer patients simultaneously. MRIdian® addresses key limitations of existing external-beam radiation therapy technologies because it integrates MRI technology, radiation delivery and proprietary software to locate, target and track the position and shape of soft-tissue tumors while radiation is delivered. Real-time MRI-imaging clearly defines the targeted tumor from the surrounding soft tissue and other critical organs during radiation treatment allowing the system to deliver radiation to the tumor accurately while delivering less radiation to healthy tissue. MRIdian®’s increased target accuracy combined with improved tumor visibility and accurate dose recording means clinicians can treat patients who would not previously have been considered radiation therapy candidates. ViewRay believes MRIdian® will significantly improve the safety and efficacy of radiation therapy, leading to improved patient outcomes with reduced side-effects from off-target radiation delivery.

Featured Items
Download Documentation Investor Presentation
Upcoming Eventsmore >
Stock Quotemore >
VRAY (Common Stock)
Exchange :NASDAQ (US Dollar)
Price :$6.15
Change (%) : Stock is Up 0.07 (1.15%)
Volume :332,373
Data as of 05/26/17 4:00 p.m. ET
Event Calendarmore >
May 2017?
Calendar Help
This calendar contains six months of past and future company related information, which may include press releases, SEC filings, calendar events and more. Dates containing information are indicated by a colored background. You may hover your mouse over a date that contains an event to reveal the event or events taking place on that day including a link to additional information. This calendar requires JavaScript to be installed and activated on your browser.
Calendar Icon Legend:
Analyst Meeting
Conference
Conference Presentation
Corporate Conference Call
Custom Events
Earnings Conference Call
Earnings Release
Financial Reports
Mergers & Acquisition Announcement
Guidance Announcement
Other Corporate
Sales Call/Presentation
Sales Release
Shareholders Meeting
News Release
SEC Filings
Presentations
52 Week High
Today
SMTWTFS
-1123
05/03/17
EFFECT
Formats:  HTML Adobe PDF Word
EFFECT
Formats:  HTML Adobe PDF Word
EFFECT
Formats:  HTML Adobe PDF Word
EFFECT
Formats:  HTML Adobe PDF Word
456
789
05/09/17
424B3
Formats:  Excel HTML Adobe PDF Word
10111213
14151617181920
2122
05/22/17
4
Formats:  HTML Adobe PDF Word
2324252627
28293031515253
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever ViewRay Inc posts new information to the site. Just enter your e-mail address and click Submit.
 
Data provided by Nasdaq. Minimum 15 minutes delayed.
Copyright 2015 © ViewRay. All rights reserved